Contact

Let's talk.

Tell us how you want to work with Bardel and the right person will reach back. Clinicians, health systems, payers, pharma teams, government partners, and patients all start the conversation here.

We reply within two business days Built in Morristown, NJ
Send a message

How can we help?

Share a few details and we will route your note to the right team. Fields marked with * are required.

By sending this, you agree that Bardel may use your details to respond to your inquiry. We will never share them.

Why teams reach out

One short conversation shows you what medicine has been missing.

Bardel turns the body's response to any treatment into objective, real-time insight. The fastest way to understand it is to watch it work on a live panel.

Two clinicians reviewing a patient's treatment-response data together on a tablet during a consultation.
Any intervention, one objective response signal, one clear answer. A short conversation is all it takes to see it.
Decades of peer-reviewed cardiac research
850+ therapeutic sessions captured.
75 devices live across 33 states.
78% monthly retention, as of 2026.
Advisors

Our advisors bring more than two centuries of combined experience to this. Among them: the leader of the U.S. Ozempic launch at Novo Nordisk and former VP of Global Commercial at Johnson & Johnson; the former President of the Aetna Medicare Division, who ran a roughly $23 billion P&L; a 40-year MedTech operator and former VP of Healthcare Investment Banking at Wells Fargo; a Cornell PhD who discovered the Spexin peptide; and the founder of Princeton Pain Management, with 40-plus years in pain medicine. Meet the team

Medicine has been flying blind. It does not have to anymore.

See the platform, or explore a partnership.

Request a demo Explore the platform Investor inquiry